Company: CGCT
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001104659-25-034635
Chunk: 6

Company: Cartesian Growth Corp III
Filing Date: 2025-04-14
Form: S-1/A
Chunk 6
---
Management — Conflicts of Interest,” each of our officers and directors presently has, and any of them in the future may have additional,
fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or
will be required to present a business combination opportunity to such entities. The low price that our initial shareholders, officers
and directors (directly or indirectly) paid for the founder shares creates an incentive whereby our initial shareholders, officers and
directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and
is unprofitable for public shareholders. If we are unable to complete our initial business combination within the completion window,
the founder shares and private placement warrants may expire worthless, except to the extent they receive liquidating distributions from
assets outside the trust account, which could create an incentive for our initial shareholders, officers and directors to complete a
transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders.
Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination
if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement
with respect to our initial business combination. Additionally, we will reimburse our sponsor in an amount equal to $10,000 per month
for office space, utilities and secretarial and administrative support made available to us, as described elsewhere in this prospectus.
Upon consummation of this offering, we will repay up to $250,000 in loans made to us by our sponsor to cover offering-related and organizational
expenses. In the event that following this offering we obtain working capital loans from our sponsor or an affiliate of our sponsor or
certain of our officers and directors to finance transaction costs related to our initial business combination, up to $1,500,000 of such
loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender,
which conversion may result in material dilution to our public shareholders. As a result, there may be actual or potential material conflicts
of interest between members of our management team, our initial shareholders, including our sponsor, and our or their respective affiliates
on the one hand, and purchasers in this offering on the other. See the sections entitled “ Summary — Initial Shareholders Information,” “ Summary — Conflicts of Interest,” “ Risk